PulseAugur
EN
LIVE 21:30:45

Neuracle's Invasive BCI Device Achieves World First Clinical Prescription

By PulseAugur Editorial · [1 sources] ·

Neuracle has achieved a significant milestone with its Neuracle NEO-ONE SCI device, marking the world's first invasive brain-computer interface (BCI) product to enter clinical use. The device received its first prescription at Shanghai Huashan Hospital, signifying the completion of its commercial cycle from regulatory approval to surgical implantation and subsequent insurance coverage. AI

IMPACT This marks a critical step in the clinical application of brain-computer interfaces, potentially paving the way for wider adoption in medical treatments.

RANK_REASON First commercial cycle completion of an invasive BCI device. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on Pandaily →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Neuracle's Invasive BCI Device Achieves World First Clinical Prescription

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
First commercial cycle completion of an invasive BCI device. [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
72 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Pandaily TIER_1 English(EN) · [email protected] (Pandaily) ·

    Neuracle Writes First Brain-Computer Interface Prescription: World First Invasive BCI Product Enters Clinical Use

    Neuracle NEO-ONE SCI receives first prescription at Shanghai Huashan Hospital, completing the world first full commercial cycle of an invasive BCI device from approval to surgery to insurance coverage.

RELATED ENTITIES

RELATED TOPICS